Mode
Text Size
Log in / Sign up
N/A N=146 Basic Science

Infant and Parent Shared Book Reading

Individual, Category, and No-label Conditions

Enrolled (actual)
146
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcome: Primary: Infant Visual Attention — .533; .358; .377; .544 Proportion of Visual Attention Duration — p==.002

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Effects of shared book reading: Labels (Behavioral)
Age
Pediatric, Adult, Older Adult · 0+ yrs
Sex
All
Sponsor
University of Florida
Primary completion
Dec 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Infant Visual Attention
.533; .358; .377; .544; .300; .351 =.002 sig
PRIMARY
Infant EEG Steady-state Evoked Potential Frequency Tagging Power
7.270; 7.506; 7.392; 7.298; 7.583; 7.108 =.557
SECONDARY
Infant and Parent EEG Synchrony
.478; .484; .461; .471; .488; .474 =.664
SECONDARY
Parent-Infant Visual Joint Attention
.356; .262; .286; .409; .222; .276 =.022 sig

Summary

This work is guided by two specific aims and is expected to result in a better understanding of the effectiveness of shared book reading as a tool for supporting parent-infant interactions and infant learning across the first year of life. This work determined the extent to which books with individually-named characters (e.g., "Boris", "Fiona") increases parent-infant joint attention and infant selective attention relative to books with generic labels (e.g., "Bear", "Bear") or no labels and whether attention differs by age. During infant-parent shared book reading joint attention was measured using dual eye-tracking. Infants and parents then returned to the lab the next day and infant selective attention and infant-parent neural synchrony was measured using EEG.

Eligibility Criteria

Inclusion Criteria

  • Infants will be included if they are typically developing and between 5.5 and 12.5 months of age, as well as their caregiver.
  • Parents 18-65 years old

Exclusion Criteria

  • Infants who were born more that 14 days premature.
  • Infants who with a history of neurological or visual deficits.
  • Infants with a history of seizures or a disorder that includes risk of seizures.
  • Infants with a parent that has a history of seizures of a disorder that includes risk of seizures.
  • Parents with a history of seizures or a disorder that includes risk of seizures.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04337372). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search